At the point when my mother passed on in May 2007 from gallbladder malignancy, I took a leave from my post as a wellbeing news hound at the Wall Street Journal with subsidizing from a Robert Wood Johnson Foundation Investigator Award. Gallbladder tumor is an uncommon infection that influences around 7,000 individuals a year in the U.s., and I needed to expound on the difficulties of creating medications for uncommon sicknesses. For the following six years, I emulated a gathering of families and researchers attempting to quicken the improvement of a medication to treat Niemann-Pick Type C infection, an uncommon and deadly cholesterol digestion system issue known as NPC that strikes basically kids.